CJC-1295 is a peptide from the growth hormone pathway family, and one of the most-researched in the field. We'll explain what it is, the difference between the versions, and what the research examines.
The information in this article is for educational purposes only and does not constitute medical advice. All products on the site are for research use only.
What is CJC-1295?
CJC-1295 is an analog of GHRH — the hormone that releases growth hormone (Growth Hormone-Releasing Hormone). In research it is examined in the context of its effect on the growth hormone axis and IGF-1.
With DAC and without DAC
There are two main versions:
- With DAC — an addition that significantly extends the molecule's duration of activity (a long half-life).
- Without DAC (also known as Mod GRF 1-29) — shorter, more time-focused activity.
The choice between the two is a central question in research, because it affects the nature of the release "pulses."
Why is it combined with Ipamorelin?
CJC-1295 is often examined together with Ipamorelin, because they act on two different, complementary pathways. We expanded on this inthe dedicated article.
Frequently asked questions
What is the practical difference between with DAC and without?
Mainly the duration of activity. We expanded in a separate article on CJC-1295 with and without DAC.
How is it reconstituted?
From powder, using bacteriostatic water andour dilution calculator.
For the research product details: CJC-1295 + DAC · CJC-1295 + Ipamorelin. See also The general guide.
Wondering where to buy peptides for laboratory-grade research? Our guide answers this.
The information is general and for educational purposes only and does not constitute medical advice. The products are for research use only.
